FDA approves first medication for obstructive sleep apnea — which also promotes weight loss
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).
Alaska Dispatch News8hOpinion
Opinion: We’ve accepted Wegovy and Zepbound. The next phase is harder.
An international committee of experts will release an interim report in early 2025 outlining criteria for diagnosing ...
This anti-diabetic drug used for weight loss has been approved by US FDA: When will India see its launch?
The FDA approves Zepbound, originally used for type 2 diabetes and weight loss, for treating obstructive sleep apnea (OSA) in ...
Newsable Asianet News on MSN19h
Weight loss drug Zepbound gets US FDA nod to treat sleep apnea; India launch expected in 2025
In a groundbreaking move, the US Food and Drug Administration (FDA) has approved the anti-diabetic drug Zepbound, also known ...
The Jerusalem Post Blogs8h
Israel News
"At a time when Israel is fighting on seven fronts, we deeply appreciate the steadfast support of our Christian friends around the world," Netanyahu said. Information ...
The New York Times20h
New York Times - Top Stories
U.S. Enters a New Political Era, Defined by Donald Trump The presidential race in 2012 ended a pattern in U.S. politics, which has since become characterized by Mr. Trump’s populism, a Times ...